EUVIMEDEUVIMED entdecken
Evaluationsstudie

Evaluation of an In-House Genetic Testing Method for Confirming Prader-Willi and Angelman Syndromes in Sri Lanka

Nirosha Kugalingam, Deepthi de Silva, Pyara Rathnayake, Navoda Atapattu, Dinali M Ranaweera, Naduviladath V Chandrasekharan

Clinical Laboratory · 2024

DOI: 10.7754/clin.lab.2024.240245 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Clinical Laboratory, 2024. Verfasst von Nirosha Kugalingam und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Prader-Willi Syndrome, Angelman Syndrome, Genetic Testing, DNA Methylation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prader-Willi syndrome (PWS, MIM 176,270) and Angelman syndrome (AS, MIM 105,830) are caused by imprinting defects of chromosome 15q11-13, with loss of maternal gene expression causing AS and paternal gene expression causing PWS. The diagnosis, once established in most cases by using a methylation-specific PCR test, enables appropriate therapeutic interventions and avoids the need for further investigations. Genetic testing for PWS/AS is limited in Sri Lanka (and in other low- and middle-income countries), mainly because parents are unable to pay for testing as these are not funded by the health service. METHODS: Ninety cases (46 female) with clinical features suggesting PWS (n = 37) and AS (n = 53), referred by a pediatric endocrinologist and a pediatric neurologist, were recruited. Clinical information and blood samples were obtained following informed consent. DNA was extracted and methylation-specific PCR (MS-PCR) was performed following bisulfite modification of DNA by using an in-house method and a kit. Results were validated using known positive controls. Parent-child trio DNA samples were used in cases with confirmed PWS and AS to determine if the disease was due to a deletion or uniparental disomy. The cost of the MS-PCR testing of the two modification methods and the microsatellite analysis was determined. RESULTS: Among the suspected PWS cases, 19/37 were positive, while 5/53 of the suspected AS cases were positive. The lower identification rate of AS is probably related to the overlap of clinical features of this condition with other disorders. The kit-based modification method was more reliable, less time-consuming, and cost-effective in our laboratory. CONCLUSIONS: The kit-based modification followed by MS-PCR described in this study enables more affordable genetic testing of suspected PWS/AS cases, and this is likely to improve patient care by targeting appropriate therapy for the affected cases. Parental genetic counselling is made possible regarding the low recurrence risk, especially where a deletion or uniparental disomy is confirmed. In MS-PCR, negative cases with a strong clinical suspicion of AS, UBE3A mutation testing is required. In addition, imprinting center mutation/deletion testing may also be needed in strongly clinically suspected, MS-PCR negative PWS and AS cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prader-Willi SyndromeAngelman SyndromeGenetic TestingDNA MethylationHumansSri LankaFemaleMaleChildChild, PreschoolPolymerase Chain ReactionAdolescentInfantReproducibility of Results

Zitieren

APA

Kugalingam, N., Silva, D., Rathnayake, P., Atapattu, N., Ranaweera, D. M., & Chandrasekharan, N. V. (2024). Evaluation of an In-House Genetic Testing Method for Confirming Prader-Willi and Angelman Syndromes in Sri Lanka. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2024.240245

Vancouver

Kugalingam N, Silva D, Rathnayake P, Atapattu N, Ranaweera DM, Chandrasekharan NV. Evaluation of an In-House Genetic Testing Method for Confirming Prader-Willi and Angelman Syndromes in Sri Lanka. Clinical Laboratory. 2024. doi:10.7754/clin.lab.2024.240245

BibTeX
@article{Kugalingam2024,
  author = {Kugalingam, Nirosha and Silva, Deepthi de and Rathnayake, Pyara and Atapattu, Navoda and Ranaweera, Dinali M and Chandrasekharan, Naduviladath V},
  title = {Evaluation of an In-House Genetic Testing Method for Confirming Prader-Willi and Angelman Syndromes in Sri Lanka},
  journal = {Clinical Laboratory},
  year = {2024},
  doi = {10.7754/clin.lab.2024.240245}
}
Kostenlos starten →